Snehal G. Patel, William M. Lydiatt, John A. Ridge,
Christine M. Glastonbury, Suresh K. Mukherji,
Ronald A. Ghossein, Margaret Brandwein-Weber,
Raja R. Seethala, A. Dimitrios Colevas, Bruce H. Haughey,
Brian O'Sullivan, and Jatin P. ShahSquamous cell carcinoma and salivary gland carcinoma of all head and neck sites except HPV-related oropharynx cancer,
nasopharynx cancer, melanoma, thyroid carcinoma, and sarcoma. Staging of the patient who presents with an occult primary
tumor and EBV-unrelated and HPV-unrelated metastatic cervical lymphadenopathy is also included.<table>
<tr>
<th>These histopathologic types of cancer ...</th>
<th>Are staged according to the classification for ...</th>
<th>And can be found in chapter ...</th>
</tr>
<tr>
<td>Nasopharyngeal cancer</td>
<td>Nasopharynx</td>
<td>9</td>
</tr>
<tr>
<td>HPV-related oropharynx cancer</td>
<td>HPV-mediated (p16+) oropharyngeal cancer</td>
<td>10</td>
</tr>
<tr>
<td>Melanoma</td>
<td>Melanoma of the skin</td>
<td>47</td>
</tr>
<tr>
<td>Mucosal melanoma</td>
<td>Mucosal melanoma of the head and neck</td>
<td>14</td>
</tr>
<tr>
<td>Thyroid carcinoma</td>
<td>Thyroid carcinoma</td>
<td>73-74</td>
</tr>
<tr>
<td>Soft tissue sarcoma</td>
<td>Soft tissue sarcoma of the head and neck</td>
<td>40</td>
</tr>
<tr>
<td>Eyelid</td>
<td>Eyelid carcinoma</td>
<td>64</td>
</tr>
</table>